< Back to scientific publications

Magazine 11.26

Brivaracetam as Early Add-On Treatment in Patients with Focal Seizures: A Retrospective, Multicenter, Real-World Study.

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Cerulli Irelli E, Chiesa V, Dainese F, De Maria G, Didato G, Di Gennaro G, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAracetam add-on First Italian‚oRk Study (BRIVAFIRST) Group.

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine 2,733

Does concealed chronic kidney disease predict survival of older patients discharged from acute care hospitals?

Authors: Corsonello A, Pedone C, Lattanzio F, Garasto S, Corica F, Bustacchini S, Guffanti EE, Abbatecola AM, Mari V, Fimognari FL, Incalzi RA.

Date: 2010

Scope of interest: ageing, geriatrics


Read details
Magazine 10,859

Tighter glycemic control is associated with ADL physical dependency losses in older patients using sulfonylureas or mitiglinides: Results from THE STUDY

Authors: Abbatecola AM, Bo M, Armellini F, D'Amico F, Desideri G, Falaschi P, Greco A, Guerrini G, Lattanzio F, Volpe C, Paolisso G

Date: 2015

Scope of interest: metabolism, diabetes


Read details
Magazine 2.3

The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study).

Authors: Ceccarelli G et al

Date: jul 21

Scope of interest: infectious disease


Read details